Back
United Therapeutics Vs. AbbVie Industry Stock Comparison
Sell
49
UTHR
United Therapeutics
Last Price:
351.26
Seasonality Move:
2.3%
Buy
51
ABBV
AbbVie
Last Price:
193.62
Seasonality Move:
8.43%
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $342.59. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $192.94. The Score for ABBV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $342.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Stock Price Chart
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.02 | Buy |
| Relative Strength Index (14 RSI): | 49.83 | Sell |
| Chaikin Money Flow: | -210533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (335.44 - 355.88) | Sell |
| Bollinger Bands (100): | (276.58 - 343.14) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 49.74 | Sell |
| Chaikin Money Flow: | -1249780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (193.69 - 197.17) | Sell |
| Bollinger Bands (100): | (162.36 - 190.1) | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 343.77 | Sell |
| 20-day SMA: | 348.9 | Sell |
| 50-day SMA: | 337.32 | Buy |
| 200-day SMA: | 269.62 | Buy |
| 8-day EMA: | 344.43 | Sell |
| 20-day EMA: | 344.47 | Sell |
| 50-day EMA: | 334.05 | Buy |
| 200-day EMA: | 285.84 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 195.09 | Sell |
| 20-day SMA: | 195.62 | Sell |
| 50-day SMA: | 187.85 | Buy |
| 200-day SMA: | 171.86 | Buy |
| 8-day EMA: | 194.47 | Sell |
| 20-day EMA: | 194.16 | Sell |
| 50-day EMA: | 188.49 | Buy |
| 200-day EMA: | 172.9 | Buy |
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.25 per share, and an increase next year of $1.21 per share.
United Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||